Advertisement

Topics

Molecular Targeting Technologies, Inc. (MTTI) and National Health Research Institutes (NHRI) Company Profile

09:07 EST 17th December 2018 | BioPortfolio

NHRI established in January 1996, is an autonomous research organization under the supervision and support of the government. NHRI is dedicated to improve the health and well-being of the people, enhance the quality of biomedical research and medical care, develop medical and pharmaceutical technology as well as train and cultivate biomedical researchers. Research units including 7 institutes, 3 centers and 1 division and core facilities such as Cell Bank, Digital Library and Bioinformatics are set up for state-of-the-art medical research. Scientists at NHRI conduct mission-oriented medical research and investigate many aspects of the basic biomedical sciences, as well as specific diseases. These range from the common problems such as aging, cancer, infectious diseases, mental disorders, occupational diseases to health policy.


News Articles [5906 Associated News Articles listed on BioPortfolio]

Molecular Targeting Technologies, Inc. Wins Exclusive License for Novel Neuroendocrine Neoplasm Drug from NIH

Molecular Targeting Technologies, Inc. (MTTI) announced today that the National Institute of Biomedical Imaging and Bioengineering (an Institute within the National Institutes of ...

Molecular Targeting Technologies, Inc. Wins Exclusive License for Novel Neuroendocrine Neoplasm ...

Molecular Targeting Technologies, Inc.Chris Pak, 610-738-7938cpak@mtarget.comorInvestorsJianwei Xu, 856-428-8168Jxu@mtarget.com Read more...

Recent Study Suggests Diabetes Treatment May Have Potential in Parkinson’s Disease

Research published in the journal Nature by researchers at the National Health Research Institutes in Taiwan and the National Institute on Aging, National Institutes of Health in the U.S. suggest that...

National Institutes of Health supports novel drug discovery research

Approximately $1.7 million in new funding from the National Institutes of Health will enable a multidisciplinary team of University of Illinois at Chicago researchers to build a reference library of b...

Minority Health and Health Disparities Research Innovation Award

(NIH/National Institute on Minority Health and Health Disparities) The National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health, has selected rec...

Children's National and NIAID launch pediatric clinical research partnership

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and Children's National Health System, a pediatric academic medical center in Washington, D.C., ha...

NIAID and Children's National partner to advance pediatric clinical research

(NIH/National Institute of Allergy and Infectious Diseases) The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and Children's National Health...

GW Researcher investigating link between parasitic infection and bile duct cancer

(George Washington University) Paul Brindley, Ph.D., at the GW School of Medicine and Health Sciences, has received more than $1.7 million from the National Cancer Institute at the National Institutes...

PubMed Articles [10967 Associated PubMed Articles listed on BioPortfolio]

Corrigendum.

Gary, R., Dunbar, S. B., Higgins, M., Butts, B., Corwin, E., Hepburn, K., … Miller, A. H. (2018). An Intervention to Improve Physical Function and Caregiver Perceptions in Family Caregivers of Perso...

The Partnership for Accelerating Cancer Therapies.

As a part of the Cancer Moonshot, the National Cancer Institute, part of the National Institutes of Health, the Foundation for National Institutes of Health, the US Food and Drug Administration, and 1...

Defining Bladder Health in Women and Girls: Implications for Research, Clinical Practice, and Public Health Promotion.

Bladder health in women and girls is poorly understood, in part, due to absence of a definition for clinical or research purposes. This article describes the process used by a National Institutes of H...

Trends in Children's Mental Health Services Research Funding: Response to Hoagwood and Colleagues' Commentary.

In their recent JACAAP commentary, Hoagwood et al. examined data extracted from the National Institutes of Health Research Portfolio Online Reporting Tools (RePORT) and concluded there has been a dec...

Portfolio Analysis on Preeclampsia and Pregnancy-associated Hypertension Research Funded by the National Heart, Lung and Blood Institute.

Chronic hypertension and preeclampsia are the most common complications of pregnancy. To clarify the contributions of the National Heart, Lung and Blood Institute (NHLBI) to the field and identify pot...

Clinical Trials [9592 Associated Clinical Trials listed on BioPortfolio]

Late Effects of Radiation Therapy and Natural History of Disease in Patients Previously Treated for Cancer at the National Institutes of Health

RATIONALE: Radiation therapy may cause side effects that appear months or years after treatment has ended. A study that evaluates patients for several years after they have undergone radia...

Intergenerational Blood Pressure Study

Our project, the Intergenerational Blood Pressure Study, is a 5 year research study funded by the National Institutes of Health/National Institute of Nursing Research and led by the Yale U...

Natural History Study of Patients With Central Nervous System Tumors Being Evaluated at the National Institutes of Health

RATIONALE: Gathering information about patients with central nervous system tumors over time may help doctors learn more about the disease and find better methods of treatment and on-going...

Evaluation of Patients With Heart Disease Not Eligible for Research Protocols

An important mission of the National Institutes of Health (NIH) is to develop and carry out research studies designed to improve understanding of disease processes and treatments. Clinica...

Re-Aiming at Hydroxyurea Adherence for Sickle Cell With mHealth

National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) guidelines recommend that hydroxyurea be offered to symptomatic adults and all children with sickle ce...

Companies [8098 Associated Companies listed on BioPortfolio]

Molecular Targeting Technologies, Inc.

Molecular Targeting Technologies, Inc. (MTTI) is a privately held US based Biotechnology Company founded to develop novel medical imaging products for the diagnosis of cardiovascu...

Molecular Targeting Technologies, Inc. (MTTI) and National Health Research Institutes (NHRI)

NHRI established in January 1996, is an autonomous research organization under the supervision and support of the government. NHRI is dedicated to improve the health and well-bein...

Molecular Targeting Technology

Molecular Targeting Technologies, Inc. (MTTI) is a privately held company engaged in the development and commercialization of unique nuclear imaging products and targeted delivery technology for diagn...

Molecular Histology Inc.

Cecil H. Fox, the president of Molecular Histology Inc., has enjoyed a long and varied career in science. A former Senior Scientist at the National Institutes of Heath, he has held positions at Yale, ...

Canadian Institutes of Health Research

Canadian Institutes of Health Research (CIHR) is the major federal agency responsible for funding health research in Canada. It aims to excel in the creation of new health knowledge, and to translate ...

More Information about "Molecular Targeting Technologies, Inc. (MTTI) and National Health Research Institutes (NHRI)" on BioPortfolio

We have published hundreds of Molecular Targeting Technologies, Inc. (MTTI) and National Health Research Institutes (NHRI) news stories on BioPortfolio along with dozens of Molecular Targeting Technologies, Inc. (MTTI) and National Health Research Institutes (NHRI) Clinical Trials and PubMed Articles about Molecular Targeting Technologies, Inc. (MTTI) and National Health Research Institutes (NHRI) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Molecular Targeting Technologies, Inc. (MTTI) and National Health Research Institutes (NHRI) Companies in our database. You can also find out about relevant Molecular Targeting Technologies, Inc. (MTTI) and National Health Research Institutes (NHRI) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record